◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

NOF Corporation (4403)

Name: NOF Corporation（4403）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Basic Materials · ウォール街（米国） · 最終更新: 2026-10-02

NOF Corporation manufactures chemicals in Japan. It operates through Functional Chemicals, Pharmaceuticals, Medicals and Health, and Explosive & Propulsion segments. The Functional Chemicals segment offers fatty acids and derivatives, surfactants, ethylene oxide and propylene oxide derivatives, organic peroxides, functional polymers, functional films, petrochemical products, and electronic materials, as well as special anti-corrosion prevention agents.

主要指標

時価総額: JPY 562 billion
売上高（2026-03-31 期末の会計年度）: JPY 258.0B
当期純利益: JPY 40.5B
売上総利益率: 34.5%
純利益率: 15.7%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
売上高合計	JPY 258.0B	JPY 238.3B	JPY 222.3B	JPY 217.7B	—
売上総利益	JPY 89.1B	JPY 85.2B	JPY 79.5B	JPY 75.9B	—
営業利益（EBIT）	JPY 47.4B	JPY 45.3B	JPY 42.1B	JPY 40.6B	—
当期純利益	JPY 40.5B	JPY 36.5B	JPY 34.0B	JPY 34.0B	—

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は 4403 のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/4403

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.